STOFF 2020

The Lansdowne | Leesburg, VA
January 30 – February 1, 2020

Agenda – PDF

Cancer Drug Development: Views from Academia
View Presentation Summaries

Cancer Drug Development: Views from Industry
View Presentation Summaries

The Cost and Value of Cancer Medicine
View Presentation Summaries

Oncology Drug Development: A Regulatory Perspective
View Presentation Summaries

Overcoming Barriers in Career Development and Progression
View Presentation Summaries

Systemic/Toxic Effects
View Presentation Summaries

Science at the Interface between the Lab and the Clinic
View Presentation Summaries

CAR T Cells and Toxicities/Efficacy
View Presentation Summaries

Phase I Clinical Trials: Hypothesis Testing
View Presentation Summaries

Issues in Design of Translational Research Trials
View Presentation Summaries

IRB Issues and Translational Research PI Responsibilities and Conflict of Interest
View Presentation Summaries

Quantitative and Systems Pharmacology Approach to Personalizing Therapy
View Presentation Summaries

Immune Checkpoint Inhibition in Advanced Cancer
View Presentation Summaries

Therapeutic Resistance Including Serial Biopsy, Rapid Autopsy and Blood-based Biomarkers Platforms
View Presentation Summary

STO gratefully acknowledges support from:

Pfizer
CHAAO
EMD Serono